171 related articles for article (PubMed ID: 23302311)
21. Identification of a clinically homogenous subgroup of benign cortisol-secreting adrenocortical tumors characterized by alterations of the protein kinase A (PKA) subunits and high PKA activity.
Vincent-Dejean C; Cazabat L; Groussin L; Perlemoine K; Fumey G; Tissier F; Bertagna X; Bertherat J
Eur J Endocrinol; 2008 Jun; 158(6):829-39. PubMed ID: 18505904
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological features, biochemical and molecular markers in 5 patients with adrenocortical carcinoma.
Kouyama R; Hiraishi K; Sugiyama T; Izumiyama H; Yoshimoto T; Akashi T; Kihara K; Homma K; Shibata H; Hirata Y
Endocr J; 2011; 58(7):527-34. PubMed ID: 21521927
[TBL] [Abstract][Full Text] [Related]
23. Discerning malignancy in adrenocortical tumors: are molecular markers useful?
Wachenfeld C; Beuschlein F; Zwermann O; Mora P; Fassnacht M; Allolio B; Reincke M
Eur J Endocrinol; 2001 Sep; 145(3):335-41. PubMed ID: 11517015
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic and prognostic assessments of adrenocortical carcinomas by pathological features, immunohistochemical markers and reticular histochemistry staining.
Gan W; Han X; Gong Y; Yang Y; Wang C; Zhang Z
Diagn Pathol; 2024 May; 19(1):71. PubMed ID: 38802933
[TBL] [Abstract][Full Text] [Related]
25. Characterization of differential gene expression in adrenocortical tumors harboring beta-catenin (CTNNB1) mutations.
Durand J; Lampron A; Mazzuco TL; Chapman A; Bourdeau I
J Clin Endocrinol Metab; 2011 Jul; 96(7):E1206-11. PubMed ID: 21565795
[TBL] [Abstract][Full Text] [Related]
26. Pediatric adrenal cortical carcinoma: brain metastases and relationship to NF-1, case reports and review of the literature.
Wagner AS; Fleitz JM; Kleinschmidt-Demasters BK
J Neurooncol; 2005 Nov; 75(2):127-33. PubMed ID: 16132517
[TBL] [Abstract][Full Text] [Related]
27. Myxoid adrenal cortical neoplasms.
Raparia K; Ayala AG; Sienko A; Zhai QJ; Ro JY
Ann Diagn Pathol; 2008 Oct; 12(5):344-8. PubMed ID: 18774497
[TBL] [Abstract][Full Text] [Related]
28. [Assessment of pro- and antiangiogenic factors blood serum concentrations in patients with hormonal inactive adrenal tumors].
Korzeniewska M; Kołomecki K; Stepień H; Naze M; Stepień T; Kuzdak K
Endokrynol Pol; 2005; 56(1):39-44. PubMed ID: 16335673
[TBL] [Abstract][Full Text] [Related]
29. Serum inhibin pro-αC is a tumor marker for adrenocortical carcinomas.
Hofland J; Feelders RA; van der Wal R; Kerstens MN; Haak HR; de Herder WW; de Jong FH
Eur J Endocrinol; 2012 Feb; 166(2):281-9. PubMed ID: 22127493
[TBL] [Abstract][Full Text] [Related]
30. Molecular pathology of adrenal cortical tumors: separating adenomas from carcinomas.
Giordano TJ
Endocr Pathol; 2006; 17(4):355-63. PubMed ID: 17525484
[TBL] [Abstract][Full Text] [Related]
31. Long-term outcome following laparoscopic adrenalectomy for large solid adrenal cortex tumors.
Palazzo FF; Sebag F; Sierra M; Ippolito G; Souteyrand P; Henry JF
World J Surg; 2006 May; 30(5):893-8. PubMed ID: 16680605
[TBL] [Abstract][Full Text] [Related]
32. Expression of the angiogenesis markers vascular endothelial growth factor-A, thrombospondin-1, and platelet-derived endothelial cell growth factor in human sporadic adrenocortical tumors: correlation with genotypic alterations.
de Fraipont F; El Atifi M; Gicquel C; Bertagna X; Chambaz EM; Feige JJ
J Clin Endocrinol Metab; 2000 Dec; 85(12):4734-41. PubMed ID: 11134136
[TBL] [Abstract][Full Text] [Related]
33. A surgical approach to adrenocortical tumors in children: the mainstay of treatment.
Stewart JN; Flageole H; Kavan P
J Pediatr Surg; 2004 May; 39(5):759-63. PubMed ID: 15137014
[TBL] [Abstract][Full Text] [Related]
34. Adrenocortical tumors: results of treatment and study of Weiss's score as a prognostic factor.
Lucon AM; Pereira MA; Mendonça BB; Zerbini MC; Saldanha LB; Arap S
Rev Hosp Clin Fac Med Sao Paulo; 2002; 57(6):251-6. PubMed ID: 12612756
[TBL] [Abstract][Full Text] [Related]
35. Outcome of adrenocortical tumors in children.
Hanna AM; Pham TH; Askegard-Giesmann JR; Grams JM; Iqbal CW; Stavlo P; Moir CR
J Pediatr Surg; 2008 May; 43(5):843-9. PubMed ID: 18485950
[TBL] [Abstract][Full Text] [Related]
36. DNA and kinetic heterogeneity during the clonal evolution of adrenocortical proliferative lesions.
Blanes A; Diaz-Cano SJ
Hum Pathol; 2006 Oct; 37(10):1295-303. PubMed ID: 16949934
[TBL] [Abstract][Full Text] [Related]
37. Adrenocortical carcinomas: a 12-year clinicopathologic study of 15 cases.
Menon V; Krishnamurthy SV
Indian J Pathol Microbiol; 2006 Jan; 49(1):7-11. PubMed ID: 16625963
[TBL] [Abstract][Full Text] [Related]
38. Expression of aromatase and estrogen receptors in human adrenocortical tumors.
Barzon L; Masi G; Pacenti M; Trevisan M; Fallo F; Remo A; Martignoni G; Montanaro D; Pezzi V; Palù G
Virchows Arch; 2008 Feb; 452(2):181-91. PubMed ID: 18157729
[TBL] [Abstract][Full Text] [Related]
39. Nestin as a marker in the classification of adrenocortical tumors.
Lachenmayer A; Lichtenauer UD; Cox T; Schott M; Malendowicz LK; Goretzki PE; Cupisti K; Scherbaum WA; Bornstein SR; Willenberg HS
Horm Metab Res; 2009 May; 41(5):397-401. PubMed ID: 19294612
[TBL] [Abstract][Full Text] [Related]
40. Matrix metalloproteinase type 2 expression in malignant adrenocortical tumors: Diagnostic and prognostic significance in a series of 50 adrenocortical carcinomas.
Volante M; Sperone P; Bollito E; Frangipane E; Rosas R; Daffara F; Terzolo M; Berruti A; Papotti M
Mod Pathol; 2006 Dec; 19(12):1563-9. PubMed ID: 16980949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]